BioCentury
ARTICLE | Clinical News

Axis Biochemicals regulatory update

October 19, 1998 7:00 AM UTC

The FDA granted marketing approval for AXI's Homocysteine IMx automated immunoassay for the amino acid homocysteine to predict cardiovascular disease. The product will be distributed in the U.S. by pa...